Stockscreener 앱 받기
31.85
2.81%
-0.92
시간 외 거래:
31.85
전일 마감가:
$32.77
열려 있는:
$33.01
하루 거래량:
553.34K
Relative Volume:
0.79
시가총액:
$1.61B
수익:
$226.84M
순이익/손실:
$3.55M
주가수익비율:
455.00
EPS:
0.07
순현금흐름:
$-12.02M
1주 성능:
-1.82%
1개월 성능:
+1.72%
6개월 성능:
-23.99%
1년 성능:
-20.55%
1일 변동 폭
$31.34
$33.01
1주일 범위
$31.34
$34.55
52주 변동 폭
$29.24
$63.00
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
VCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
31.85 | 1.65B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Vericel (NASDAQ:VCEL) Receives "Sell (D+)" Rating from Weiss Ratings - MarketBeat
What moving averages say about Vericel Corporation2025 Top Decliners & Consistent Return Investment Signals - newser.com
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Unique Financial Metrics - Markets Mojo
Will Vericel Corporation see short term momentum2025 AllTime Highs & Growth Focused Entry Reports - newser.com
What data driven models say about Vericel Corporation’s futureEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com
State of Alaska Department of Revenue Has $1.28 Million Stock Position in Vericel Corporation $VCEL - Defense World
Vericel Corporation $VCEL Shares Purchased by PFG Investments LLC - MarketBeat
Assessing Vericel (VCEL) Valuation After Recent Share Price Volatility - simplywall.st
Why Vericel Corporation (ATQP) stock gets analyst attention2025 Top Decliners & Expert Approved Trade Ideas - newser.com
GAMMA Investing LLC Cuts Holdings in Vericel Corporation $VCEL - Defense World
Park Avenue Securities LLC Invests $243,000 in Vericel Corporation $VCEL - Defense World
Real time breakdown of Vericel Corporation stock performanceFed Meeting & High Accuracy Swing Entry Alerts - newser.com
How to manage a losing position in Vericel CorporationCPI Data & Community Consensus Stock Picks - newser.com
What does recent volatility data suggest for Vericel CorporationWeekly Gains Report & Growth Focused Entry Point Reports - newser.com
Can Vericel Corporation (ATQP) stock survive global slowdownPrice Action & Precise Entry and Exit Recommendations - newser.com
Does Vericel Corporation show high probability of reboundJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
What technical models suggest about Vericel Corporation’s comebackPortfolio Growth Summary & Real-Time Stock Price Movement Reports - newser.com
Vericel director Robert Zerbe sells $156,250 in stock - MSN
Vericel Corp. Experiences Valuation Adjustment Amid Unique Market Dynamics and Performance Metrics - Markets Mojo
Understanding Vericel Corporation’s price movementAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com
Will Vericel Corporation benefit from macro trendsWall Street Watch & Weekly Top Gainers Trade List - newser.com
Vericel Corp. Hits New 52-Week Low at $29.24 Amidst Declining Performance - Markets Mojo
Vericel Corporation $VCEL Shares Acquired by Congress Asset Management Co. - Defense World
Vericel (NASDAQ:VCEL) Hits New 12-Month LowTime to Sell? - MarketBeat
Vericel stock hits 52-week low at 29.77 USD By Investing.com - Investing.com South Africa
Vericel stock hits 52-week low at 29.77 USD - Investing.com India
Kopp Family Office LLC Sells 8,554 Shares of Vericel Corporation $VCEL - MarketBeat
How to build a custom watchlist for Vericel CorporationQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Diversified Trust Co Grows Stock Holdings in Vericel Corporation $VCEL - Defense World
Voya Investment Management LLC Purchases 10,048 Shares of Vericel Corporation $VCEL - Defense World
Strs Ohio Takes Position in Vericel Corporation $VCEL - MarketBeat
Vericel Corporation stock trend forecastQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Vericel Corp. Experiences Revision in Its Stock Evaluation Amidst Unique Market Metrics - Markets Mojo
Vericel (NASDAQ:VCEL) Downgraded to Neutral Rating by BTIG Research - MarketBeat
InvestingPro’s Vericel overvaluation call leads to 41% decline prediction By Investing.com - Investing.com
18,200 Shares in Vericel Corporation $VCEL Purchased by Strs Ohio - Defense World
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
베리셀 주식 (VCEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Sep 02 '25 |
Option Exercise |
18.00 |
10,000 |
180,000 |
76,363 |
| Hopper Jonathan Mark | Chief Medical Officer |
Sep 02 '25 |
Sale |
35.77 |
10,000 |
357,700 |
66,363 |
5.74%
자본화:
|
볼륨(24시간):